Gallbladder cancer
Gallbladder cancer (GBC) is the most common cancer of the biliary tract, characterized by a
very poor prognosis when diagnosed at advanced stages owing to its aggressive behaviour …
very poor prognosis when diagnosed at advanced stages owing to its aggressive behaviour …
[HTML][HTML] Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update
Gallbladder cancer is a malignancy of biliary tract which is infrequent in developed countries
but common in some specific geographical regions of developing countries. Late diagnosis …
but common in some specific geographical regions of developing countries. Late diagnosis …
miRNAs orchestration of gallbladder cancer-Particular emphasis on diagnosis, progression and drug resistance
Gallbladder cancer (GBC) is characterized by a highly invasive nature and a poor prognosis,
with adenocarcinoma being the main histological subtype. According to statistical data …
with adenocarcinoma being the main histological subtype. According to statistical data …
Overview of current targeted therapy in gallbladder cancer
X Song, Y Hu, Y Li, R Shao, F Liu, Y Liu - Signal Transduction and …, 2020 - nature.com
Gallbladder cancer (GBC) is rare, but is the most malignant type of biliary tract tumor.
Unfortunately, only a small population of cancer patients is acceptable for the surgical …
Unfortunately, only a small population of cancer patients is acceptable for the surgical …
Gallbladder cancer: current multimodality treatment concepts and future directions
N Sturm, JS Schuhbaur, F Hüttner, L Perkhofer… - Cancers, 2022 - mdpi.com
Simple Summary Gallbladder cancer is the most common malignancy of the biliary tract and
is associated with several risk factors such as female sex, ethnic background, and chronic …
is associated with several risk factors such as female sex, ethnic background, and chronic …
Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
J Lin, X Peng, K Dong, J Long, X Guo, H Li… - Nature …, 2021 - nature.com
Gallbladder carcinoma is the most common cancer of the biliary tract with dismal survival
largely due to delayed diagnosis. Biliary tract intraepithelial neoplasia (BilIN) is the common …
largely due to delayed diagnosis. Biliary tract intraepithelial neoplasia (BilIN) is the common …
UCP2 promotes proliferation and chemoresistance through regulating the NF-κB/β-catenin axis and mitochondrial ROS in gallbladder cancer
J Yu, L Shi, W Lin, B Lu, Y Zhao - Biochemical pharmacology, 2020 - Elsevier
Abstract Uncoupling protein 2 (UCP2) is a mitochondrial anion carrier which plays a key role
in energy homeostasis. UCP2 is deregulated in several human cancers and has been …
in energy homeostasis. UCP2 is deregulated in several human cancers and has been …
Evolving paradigms in the systemic treatment of advanced gallbladder cancer: updates in year 2022
ZI Hu, KH Lim - Cancers, 2022 - mdpi.com
Simple Summary Gallbladder cancer is distinct type of biliart tract cancer that is rare,
aggressive and with limited treatment options aside from surgical resection. As of now in …
aggressive and with limited treatment options aside from surgical resection. As of now in …
[HTML][HTML] Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients
P Yang, M Javle, F Pang, W Zhao… - … surgery and nutrition, 2019 - ncbi.nlm.nih.gov
Background Gallbladder cancer (GBC) is often diagnosed at an advanced stage with limited
therapeutic options and poor prognosis. The five-year survival rate of this cancer when …
therapeutic options and poor prognosis. The five-year survival rate of this cancer when …
Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy
Gallbladder cancer is the most common and aggressive malignancy of the biliary tract. The
complete surgical resection is the only potentially curative approach in early stage; however …
complete surgical resection is the only potentially curative approach in early stage; however …